Globally, more than 1 billion people currently live with obesity.
Weight loss jab could be used to slow progression of Alzheimer’s disease in major breakthrough - Liraglutide, sold under the ...
A new guideline from WHO conditionally recommends the use of GLP-1s to treat obesity as well as including the drugs as part ...
FAT jab users have been told to do a specific exercise or risk ageing 10 years. New research reveals popular weight-loss injections, such as Mounjaro and Wegovy, can reduce lean muscle as well as ...
GLP-1 agonist drugs essentially mimic the hormone’s action. Quite a few have been developed, including semaglutide, ...
The global health body issued its first guidance on the use of blockbuster weight loss drugs. View on euronews ...
A new study for the HSE has found that making the weight loss drug Mounjaro available to public patients would not be value ...
New precautions added for GLP-1 drugs as reports of mood changes and contraceptive concerns emerge in Australia.
The World Health Organization has released its first-ever guidelines for the safe and effective use of GLP-1 medications for ...
Irish Examiner on MSN
Cost of weight-loss drug Mounjaro too high to cover for 900,000 people who need it, pharma watchdog says
Estimate of more than €5.2bn over five years was too high, National Centre for Pharmacoeconomics found ...
Everyday Health on MSN
5 Myths About GLP-1s for Weight Loss
Uncover common misconceptions about GLP-1s for weight loss. Learn the importance of diet, exercise, managing side effects, ...
Global News - Inquirer.net on MSN
Thinness obsession prompts diet drug misuse in South Korea
A wave of demand for weight-loss medication is sweeping South Korea, a country that remains one of the OECD’s leanest, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results